Literature DB >> 32132415

Editorial: Nitro-fatty acids: novel drug candidates for the co-treatment of atherosclerosis and nonalcoholic fatty liver disease.

Oren Rom1, Yuhao Liu1, Lin Chang1, Y Eugene Chen1, Michael Aviram2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32132415      PMCID： PMC7534545          DOI： 10.1097/MOL.0000000000000666

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN： 0957-9672            Impact factor:   4.616


× No keyword cloud information.
  22 in total

Review 1.  Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?

Authors:  Amedeo Lonardo; Fabio Nascimbeni; Alessandro Mantovani; Giovanni Targher
Journal:  J Hepatol       Date:  2017-11-06       Impact factor: 25.083

Review 2.  Inflammatory signaling and metabolic regulation by nitro-fatty acids.

Authors:  Oren Rom; Nicholas K H Khoo; Y Eugene Chen; Luis Villacorta
Journal:  Nitric Oxide       Date:  2018-03-22       Impact factor: 4.427

3.  Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand.

Authors:  Francisco J Schopfer; Yiming Lin; Paul R S Baker; Taixing Cui; Minerva Garcia-Barrio; Jifeng Zhang; Kai Chen; Yuqing E Chen; Bruce A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-08       Impact factor: 11.205

4.  Nitro-fatty acids reduce atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Tanja K Rudolph; Volker Rudolph; Martin M Edreira; Marsha P Cole; Gustavo Bonacci; Francisco J Schopfer; Steven R Woodcock; Andreas Franek; Michaela Pekarova; Nicholas K H Khoo; Alyssa H Hasty; Stephan Baldus; Bruce A Freeman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-02-18       Impact factor: 8.311

5.  Nitro-Oleic Acid Reduces J774A.1 Macrophage Oxidative Status and Triglyceride Mass: Involvement of Paraoxonase2 and Triglyceride Metabolizing Enzymes.

Authors:  Mira Rosenblat; Oren Rom; Nina Volkova; Michael Aviram
Journal:  Lipids       Date:  2016-06-25       Impact factor: 1.880

6.  Electrophilic nitro-fatty acids inhibit vascular inflammation by disrupting LPS-dependent TLR4 signalling in lipid rafts.

Authors:  Luis Villacorta; Lin Chang; Sonia R Salvatore; Tomonaga Ichikawa; Jifeng Zhang; Danica Petrovic-Djergovic; Lingyun Jia; Harald Carlsen; Francisco J Schopfer; Bruce A Freeman; Y Eugene Chen
Journal:  Cardiovasc Res       Date:  2013-01-17       Impact factor: 10.787

7.  Novel gene regulatory networks identified in response to nitro-conjugated linoleic acid in human endothelial cells.

Authors:  Haocheng Lu; Jinjian Sun; Wenying Liang; Jifeng Zhang; Oren Rom; Minerva T Garcia-Barrio; Shengdi Li; Luis Villacorta; Francisco J Schopfer; Bruce A Freeman; Y Eugene Chen; Yanbo Fan
Journal:  Physiol Genomics       Date:  2019-05-10       Impact factor: 3.107

8.  Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice.

Authors:  Oren Rom; Guan Xu; Yanhong Guo; Yunhao Zhu; Huilun Wang; Jifeng Zhang; Yanbo Fan; Wenying Liang; Haocheng Lu; Yuhao Liu; Michael Aviram; Zhipeng Liu; Seongho Kim; Wanqing Liu; Xueding Wang; Y Eugene Chen; Luis Villacorta
Journal:  EBioMedicine       Date:  2019-02-13       Impact factor: 8.143

9.  Pharmacokinetic and Pharmacodynamic Effects of Oral CXA-10, a Nitro Fatty Acid, After Single and Multiple Ascending Doses in Healthy and Obese Subjects.

Authors:  Rachel M Garner; Diane R Mould; Carla Chieffo; Diane K Jorkasky
Journal:  Clin Transl Sci       Date:  2019-08-12       Impact factor: 4.689

10.  In situ generation, metabolism and immunomodulatory signaling actions of nitro-conjugated linoleic acid in a murine model of inflammation.

Authors:  Luis Villacorta; Lucia Minarrieta; Sonia R Salvatore; Nicholas K Khoo; Oren Rom; Zhen Gao; Rebecca C Berman; Soma Jobbagy; Lihua Li; Steven R Woodcock; Y Eugene Chen; Bruce A Freeman; Ana M Ferreira; Francisco J Schopfer; Dario A Vitturi
Journal:  Redox Biol       Date:  2018-01-12       Impact factor: 11.799
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.